ClinicalTrials.Veeva

Menu

The Effect of Chocolate on Vascular Function of Endurance Runners

A

Aristotle University Of Thessaloniki

Status

Not yet enrolling

Conditions

Vascular Function

Treatments

Other: White chocolate Intervention
Other: Dark chocolate Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06440512
EC-161/2023

Details and patient eligibility

About

The aim of this study is to examine the effects of chocolate on the vascular function of endurance runners through a crossover study involving male runners consuming both dark and white chocolate.

Full description

Participants will be male endurance runners who will receive both black and white chocolate interventions. Arterial stiffness, cardiovascular parameters, respiratory parameters, and running performance will be assessed before and after each intervention period. The study will involve a two-week intervention period for each type of chocolate, with a washout period in between. The primary outcome measure will be arterial stiffness, while secondary outcome measures will include cardiovascular and respiratory parameters, as well as running performance. The study is expected to provide insights into the effects of chocolate consumption on vascular function in endurance athletes.

Enrollment

50 estimated patients

Sex

Male

Ages

25 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Gender: Male
  • Age: 25-55 years
  • Healthy status
  • Active endurance runner
  • Regular physical activity (at least 3 times per week)
  • Availability on specific days and times for research sessions
  • Willingness and consistency

Exclusion criteria

  • Allergies or Intolerances: Participants with known allergies or intolerances to chocolate or any of its ingredients.
  • Cardiovascular Diseases: Participants with known cardiovascular diseases or history of cardiac episodes.
  • Metabolic Disorders: Individuals with diabetes or other metabolic disorders that may affect glucose and insulin metabolism.
  • Contradictory Diet: Individuals following specific diets that may affect the study, such as high or low flavonoid diets.
  • Medication Use: Individuals taking medications that affect vascular function, such as antihypertensives or anticoagulants.
  • Smoking: Smokers or individuals who have quit smoking within the last six months.
  • Substance Abuse: Individuals with a history of alcohol or substance abuse.
  • Patients with Chronic Diseases: Individuals with serious chronic diseases that may affect the study outcomes.
  • Participation in Other Studies: Individuals participating in other clinical trials or research that may affect the study outcomes.
  • Physical Condition: Individuals who are not regular runners or who do not exercise regularly at a level similar to other participants.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

50 participants in 2 patient groups

A Chocolate Arm
Experimental group
Description:
Intervention period 1:The group will consume 50 grams of dark chocolate daily for two weeks. Washout period: Two-weeks Intervention period 2: The group will consume 40 grams of white chocolate daily for two weeks.
Treatment:
Other: Dark chocolate Intervention
Other: White chocolate Intervention
B Chocolate Arm
Experimental group
Description:
Intervention period 1:The group will consume 40 grams of white chocolate daily for two weeks. Washout period: Two-weeks Intervention period 2: The group will consume 50 grams of dark chocolate daily for two weeks
Treatment:
Other: Dark chocolate Intervention
Other: White chocolate Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Zacharias Vordos, PhD; Asterios Deligiannis, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems